VRTX Jan 2025 250.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:17AM EDT. Market open.
| Previous Close | 170.90 |
| Open | 170.73 |
| Bid | 210.00 |
| Ask | 219.50 |
| Strike | 250.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 170.73 - 170.90 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
GuruFocus.comInsider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
ZacksWhy Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksVertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
© 2024 Yahoo. All rights reserved.